©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2481-2492
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2481
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2481
Table 1 Study design and the treatments
| Groups | Treatment (mg/mL per rat, i.col.) | Ethanol (%) | Position (cm to anus) | Time points for evaluation | ||
| 5 d | 4 wk | 8 wk | ||||
| 1 | TNBS, 20/0.4 per rat | 50 | 8 | IE | IE | - |
| 2 | TNBS, 20/0.8 per rat | 50 | 8 | IE | IE | - |
| 3 | TNBS, 10/0.8 per rat | 50 | 8 | IE | IE | - |
| 4 | TNBS, 5/0.8 per rat | 50 | 8 | IE | IE/PE | PE/EE |
| 5 | TNBS, 5/0.8 per rat | 50 | 4 | IE | IE/PE | PE |
| 6 | TNBS, 5/0.8 per rat | 25 | 8 | IE | IE/PE | PE |
| 7 | Saline, 0.8/rat | - | 8 | IE | IE/PE | PE/EE |
- Citation: Qin HY, Xiao HT, Wu JC, Berman BM, Sung JJ, Bian ZX. Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats. World J Gastroenterol 2012; 18(20): 2481-2492
- URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2481.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i20.2481